how do glp-1 agonists work Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide 1 Receptor Agonists: A Scoping Review Current Insights, Advantages and Challenges
Description
Author's Bio: Katie Bailey, MS, RD, LD, FNCHi everyone
New users of GLP-1RAs were matched based on age, demographics, comorbidities and medication use by using 1:1 propensity matching with other glucose-lowering drugs
With so many people interested in using GLP-1 agonists off-label to lose a few extra pounds, what does it mean for this class of drugs?
A pattern of musculoskeletal injuries spurred researchers to conduct a study on whether using the popular weight-loss and diabetes drugs increased a persons risk of other health conditions.
In the subgroup analyses, human GLP-1 RAs, but not nonhuman GLP-1 RAs, reduced the risk of MACE in patients with HF (p interaction = 0.11)
